Defects in platelet adhesion at sites of injury can lead to excessive bleeding. A study by Gandhi et al. investigates a new bispecific antibody as a possible therapy to prevent bleeding in patients with inherited defects in platelet adhesion.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Orsini, S. et al. Haematologica 102, 1192–1203 (2017).
Fiore, M. et al. Br. J. Haematol. 181, 173–182 (2018).
Siddiq, S. et al. Haemophilia. 17, e858–e869 (2011).
Lisman, T. et al. Blood 103, 1720–1727 (2004).
Poon, M. C. Thromb. Haemost. 121, 332–340 (2021).
Friend, B. D. et al. J. Pediatr. Hematol. Oncol. 42, e521–e526 (2020).
Palma-Barqueros, V. et al. Haemophilia 28 (S1), Abstract SP022 (2022).
Gandhi, P. et al. Nat. Cardiovas. Res. https://doi.org/10.1038/s44161-023-00418-4 (2024).
Washington, A. V. et al. Blood 104, 1042–1047 (2004).
Morrissey, J. H. et al. Blood 81, 734–744 (1993).
Andiç, N. et al. Blood Coagul. Fibrinolysis 32, 349–351 (2021).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors report no competing interests.
Rights and permissions
About this article
Cite this article
Fager, A.M., Monroe, D.M. Stopping the bleed when platelets don’t stick. Nat Cardiovasc Res 3, 100–101 (2024). https://doi.org/10.1038/s44161-024-00421-3
Published:
Issue Date:
DOI: https://doi.org/10.1038/s44161-024-00421-3